Global Opioid-Induced Constipation Market 2018-2022

Global Opioid-Induced Constipation Market 2018-2022

About this market

Rise in incidence of chronic diseases such as arthritis, back pain, and migraine is likely to drive growth in the market. The incidence of chronic pain is increasing across the world, owing to the several reasons, including lifestyle changes, rise in number of injuries, growth in number of surgeries, and painful medical conditions. Technavio’s analysts have predicted that the opioid-induced constipation market will register a CAGR of more than 32% by 2022.

Market Overview

Rise in OIC cases among elderly

Rise in incidences of diseases associated with old age, impaired body functions, and increase in the use of medicines such as antidepressants and anticholinergics have collectively led to high prevalence of constipation among the elderly population. This drives growth in the opioid-induced constipation market.

Use of conventional laxatives for OIC

The use of laxatives for OIC is a major challenge that is reducing sales of approved drugs meant for the treatment of OIC.

For the detailed list of factors that will drive and challenge the growth of the opioid-induced constipation market during the 2018-2022, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Takeda Pharmaceutical and Merck the competitive environment is quite intense. Factors such as the rise in incidence of chronic diseases such as arthritis, back pain, and migraine and the rise in OIC cases among elderly, will provide considerable growth opportunities to opioid-induced constipation manufactures. AstraZeneca, Bausch Health, Takeda Pharmaceutical, and Merck are some of the major companies covered in this report.


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline molecules for OIC
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ mn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by route of administration
    • Segmentation by route of administration
      • Table Route of administration - Market share 2017-2022 (%)
    • Comparison by application
      • Table Comparison by application
    • Oral - Market size and forecast 2017-2022
      • Table Oral - Market size and forecast 2017-2022 ($ mn)
      • Table Oral route - Year-over-year growth 2018-2022 (%)
    • Parenteral - Market size and forecast 2017-2022
      • Table Parenteral - Market size and forecast 2017-2022 ($ mn)
      • Table Parenteral route - Year-over-year growth 2018-2022 (%)
    • Market opportunity by application
      • Table Market opportunity by application
  • Market segmentation by class of drugs
    • Segmentation by class of drugs
    • Peripherally acting mu-opioid receptor antagonist
    • Locally acting chloride channel activator
    • Others
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ mn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ mn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ mn)
      • Table EMEA - year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Rise in incidence of chronic diseases such as arthritis, back pain, and migraine
    • Market dominance by opioid receptor antagonists
    • Introduction of separate diagnostic guidelines for idiopathic or functional constipation and OIC
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AstraZeneca
      • Table AstraZeneca overview
      • Table AstraZeneca - Business segments
      • Table AstraZeneca - Organizational developments
      • Table AstraZeneca - Geographic focus
      • Table AstraZeneca - Key offerings
    • Bausch Health
      • Table Bausch Health overview
      • Table Bausch Health - Business segments
      • Table Bausch Health - Organizational developments
      • Table Bausch Health - Geographic focus
      • Table Bausch Health - Segment focus
      • Table Bausch Health - Key offerings
    • Takeda Pharmaceutical
      • Table Takeda Pharmaceutical overview
      • Table Takeda Pharmaceutical - Business segments
      • Table Takeda Pharmaceutical - Organizational developments
      • Table Takeda Pharmaceutical - Geographic focus
      • Table Takeda Pharmaceutical - Key offerings
    • Merck
      • Table Merck overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook